TC10 Activators encompass a diverse group of chemicals that can influence the activity of the RHOQ protein, either directly or through indirect modulation of associated signaling pathways. These activators, while not exclusively targeting RHOQ, play a pivotal role in the intricate network of cellular signaling, often affecting multiple Rho GTPases and their downstream effectors.
Among the notable activators, EGF (Epidermal Growth Factor) and Lysophosphatidic acid (LPA) are prominent. EGF, upon binding to its receptor EGFR, can activate various Rho GTPases, thereby influencing RHOQ. LPA, on the other hand, is recognized for its ability to activate several members of the Rho family GTPases, suggesting a possible indirect effect on RHOQ activity. Calpeptin, a calpain inhibitor, and Y-27632, a ROCK inhibitor are chemicals that can influence the downstream signaling of Rho GTPases, offering another avenue through which RHOQ can be modulated. Additionally, compounds like NSC23766 and ML141, which target Rac1 and Cdc42 respectively, might modulate RHOQ through shared or interconnected pathways. The cellular cytoskeleton, particularly actin dynamics, plays a crucial role in Rho GTPase signaling. Chemicals like Latrunculin A, which disrupts actin polymerization, and Jasplakinolide, which stabilizes actin filaments, can thereby influence the signaling pathways in which RHOQ is involved.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA is known to activate several Rho family GTPases, which may indirectly affect RHOQ activity. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
As a calpain inhibitor, it can potentially influence Rho GTPase signaling, including RHOQ. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that can influence downstream Rho GTPase signaling, potentially affecting RHOQ. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Targets Rac1 and can indirectly influence other Rho GTPases like RHOQ. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Cdc42 inhibitor that might indirectly modulate RHOQ through shared pathways. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Disrupts actin polymerization, potentially influencing Rho GTPase signaling, including RHOQ. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, potentially affecting Rho GTPase signaling pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels which can influence Rho GTPase signaling, potentially affecting RHOQ. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor that might indirectly modulate RHOQ through MAPK/ERK pathway. | ||||||
IPA 3 | 42521-82-4 | sc-204016 sc-204016A | 5 mg 50 mg | $94.00 $458.00 | 6 | |
PAK1 inhibitor that can influence Rho GTPase signaling, potentially affecting RHOQ. | ||||||